Evaluation of Clinical Pharmacist Led Guidance on Treatment Outcomes, Treatment Adherence & Quality of Life Among T2DM Patients Attending Endocrinology Out Patient Department in a Tertiary Care Hospital

Vol 8 No 9 (2025): Volume 08 Issue 09 September 2025

Article Date Published : 13 September 2025 | Page No.: 4578-4585 | Google Scholar | Crossref doi for this article

Abstract :

Clinical pharmacist‐led guidance was evaluated in a 6‑month prospective observational study of 90 T2DM patients at a tertiary care hospital. Participants were distributed into test (Group A; n = 45) and control (Group B; n = 45) groups. Group A received structured clinical pharmacist counselling on medication regimens, adherence, lifestyle modifications, and ADR monitoring, whereas Group B received standard care. Outcomes measured at baseline and 2 months included glycaemic profiles, lipid profile, medication adherence (MARS‑10), and quality of life (WHOQOL‑BREF). Group A exhibited significant improvements in FBS, PPBS, medication adherence, and quality of life physical and psychological domains. HbA1c and lipid profile showed favourable but non‑significant trends. No major ADRs were reported. These findings support integration of pharmacist‑led guidance and care in chronic disease management.

Keywords :

Clinical Pharmacist, MARS 10, Medication Adherence, Quality of life., Type 2 Diabetes Mellitus, WHOQOL BREF.

References :

  1. United Nations. Diabetes epidemic in India. 2024. Available from: https://news.un.org/en/story/2024/11/1156971
  2. World Health Organization. Diabetes fact sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  3. India Science & Technology. Exploring the diabetes epidemic in India. Available from: https://www.indiascienceandtechnology.gov.in/featured-science/exploring-diabetes-epidemic-india
  4. American Diabetes Association. Improving patient adherence. Clinical Diabetes.
  5. American Diabetes Association. Determinants of adherence to diabetes medications. Diabetes Care.
  6. Tiwari K, et al. Prescribing pattern and ADA guideline adherence in T2DM patients. J Family Med Prim Care. 2022;11:6159–64.
  7. Kumar A, et al. Analysis of prescribing pattern and ADRs in T2DM. Asian J Pharm Res Health Care. 2021;13:125–31.
  8. Wiley Journal of Clinical Pharmacy and Therapeutics. 2024; Article ID 5518977.
  9. Hospital Pharmacy. 2020. DOI: 10.1177/0018578720973881
  10. https://pubmed.ncbi.nlm.nih.gov/35521013/
  11. https://www.frontiersin.org/articles/10.3389/fpubh.2024.1323102/full
  12. https://www.mdpi.com/2226-4787/12/5/148
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC4311350/

Author's Affiliation

   Samrat Dutta
M. Pharmacy (Pharmacology), Aditya College of Pharmacy, Surampalem – 533437, Andhra Pradesh, India.

   K. Ravishankar
Professor and Principal, Aditya College of Pharmacy, Surampalem – 533437, Andhra Pradesh, India.

Copyrights & License

Samrat Dutta, K. Ravishankar, 2025

This work is licenced under a Creative Commons Attribution 4.0 International License.

Article Details

How to Cite :

Evaluation of Clinical Pharmacist Led Guidance on Treatment Outcomes, Treatment Adherence & Quality of Life Among T2DM Patients Attending Endocrinology Out Patient Department in a Tertiary Care Hospital. Samrat Dutta, K. Ravishankar, 8(9), 4578-4585. Retrieved from https://ijcsrr.org/single-view/?id=23999&pid=23903

Most read articles by the same author(s)

Samrat Dutta, K. Ravishankar,

View

126

Citation

Downloads

Article Details